Associate Professor Lisa C. Rohan, PhD is part of a multi-institutional team led by Dr. Craig Hendrix from Johns Hopkins University on the grant entitled Delivery of Rectal Enema as Microbicide (DREAM). The development of a Rectal Enema as Microbicide (DREAM) Program addresses the critical need to develop a highly effective, safe, and more behaviorally-congruent alternative for the prevention of rectal HIV infection. The overall goal of the program is to develop a single dose pericoital enema to deliver a tenofovir (TFV) prodrug capable of providing one week of HIV protection. Rohan leads the activities related to enema product development to support efforts within the program.
Associate Professor Lisa C. Rohan, PhD is part of a multi-institutional team led by Dr. Kenneth Palmer from the University of Pittsburgh on the grant entitled Griffithsin-based Rectal Microbicides for Prevention of Viral Entry (PREVENT) . Rohan serves as the PI for the PREVENT Product Development Core for the Program. PREVENT (Pre-exposure prevention of viral entry) is an Integrated Preclinical/Clinical Program, with the overall goal to provide a comprehensive set of data to facilitate an informed decision on whether the antiviral lectin Griffithsin (GRFT) shoul progress in the topical microbicides pipeline
Associate Professor Lisa C. Rohan is part of the team led by Ian McGowan MD on a grant from Janssen entitled Employing Pharmacology in Human Disease Relevant Tissue to Support Pharmaceutical Discovery in Inflammatory Bowel Disease. Her role in this program is to study the permeability characteristics of inflammatory bowel diseased tissues in comparison with that of normal tissues to develop a model for evaluation of drug candidates for treatment of IBD including ulcerative colitis and Crohn’s disease.
Rohan is an associate professor in the pharmaceutical sciences department at the School of Pharmacy.
